Mediastinitis overview

Revision as of 17:24, 30 October 2015 by Anthony Gallo (talk | contribs)
Jump to navigation Jump to search

Mediastinitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Mediastinitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Other Imaging Findings

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Mediastinitis overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mediastinitis overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Mediastinitis overview

CDC on Mediastinitis overview

Mediastinitis overview in the news

Blogs on Mediastinitis overview

Directions to Hospitals Treating Mediastinitis

Risk calculators and risk factors for Mediastinitis overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Anthony Gallo, B.S. [2]

Overview

Mediastinitis is inflammation or infection of the tissues in the mid-chest, or mediastinum.[1] This disorder is rare, but is most often observed among patients following chest surgery or endoscopy. Mediastinitis may occur at any age.[2] It may be classified according to cause into 2 groups: acute or chronic (sclerosing or fibrosing). Acute mediastinitis is usually bacterial and due to rupture of organs in the mediastinum. Chronic sclerosing (or fibrosing) mediastinitis, while potentially serious, is caused by a long-standing inflammation of the mediastinum, leading to growth of acellular collagen and fibrous tissue within the chest and around the central vessels and airways. Life threatening causes of mediastinitis include esophageal perforation. Common causes of mediastinitis include trauma, beta-hemolytic streptococcus, forceful or constant vomiting, and median sternotomy. If left untreated, fibrosing mediastinitis may progress to sepsis and subsequently, death. The presence of mediastinitis among patients following chest surgery is observed to have a particularly poor prognosis; there is a serious risk of death.[3] Common complications of mediastinitis include sepsis and spread of the infection. Symptoms of mediastinitis include chest pain, malaise, and shortness of breath.[4] Common physical examination findings of mediastinitis include clinical signs of sepsis, tachycardia, and tachypnea.[5] CT scan may be diagnostic of mediastinitis. On CT scan, findings suggestive of mediastinitis include the presence of calcified mediastinal mass. The mainstay of therapy in acute mediastinitis secondary to cardiothoracic surgery includes clindamycin and ceftriaxone. The preferred regimen for preoperative prophylaxis against acute mediastinitis includes either a second generation cephalosporin or vancomycin. Aggressive surgical debridement is recommended among patients with descending necrotizing mediastinitis.

Historical Perspective

Chronic mediastinitis was first described by Dr. Thomas T. Whipham, MD, a British physician, in 1899.[6]

Classification

Mediastinitis may be classified according to cause into 2 groups: acute or chronic (sclerosing or fibrosing).[7]

Pathophysiology

Mediastinitis is the inflammation or infection of the mediastinum.[1] The pathogenesis of the infection remains unknown; radiographic, serologic, and/or histopathologic evidence of prior Histoplasma capsulatum infection, histoplasmosis, or chronic granulomatous disease is always observed.[8] Additionally, mediastinitis may also present as the result of Staphylococcus aureus or Staphylococcus epidermidis infection following chest surgery.[9]

Causes

Esophageal perforation is a life-threatening cause of mediastinitis. Common causes of mediastinitis include infection, trauma, endoscopy, and forceful vomiting.

Differential Diagnosis

Mediastinitis must be differentiated from superior vena cava syndrome and Hodgkin's lymphoma.[10]

Natural History, Complications and Prognosis

If left untreated, fibrosing mediastinitis may progress to sepsis and subsequently, death. Common complications of mediastinitis include sepsis and spread of the infection. Patients with mediastinitis following chest surgery have a poor prognosis.[3]

Diagnosis

History and Symptoms

Symptoms of mediastinitis include chest pain, malaise, and shortness of breath.

Physical Examination

Common physical examination findings of mediastinitis include clinical signs of sepsis, tachycardia, and tachypnoea.[5]

Laboratory Findings

Laboratory findings consistent with the diagnosis of mediastinitis include positive confirmation of organisms found upon culture of the mediastinum, including Staphylococcus aureus and Histoplasma capsulatum.[11]

CT

On CT scan, the appearance of mediastinitis can be variable and dependent on the pattern of involvement. Typically, the disease affects the middle mediastinum and may demonstrate mediastinal or hilar mass, infiltrative regions of soft-tissue attenuation which obliterate normal mediastinal fat planes and encase or invade adjacent structures, or calcifications of the central mass or associated lymph nodes (especially if there has been preceding histoplasmosis).[12]

MRI

On MRI, mediastinitis is characterized by mediastinal or hilar mass or soft-tissue attenuation. Pattern of involvement is essentially similar to CT scan for mediastinitis.[12]

Treatment

Medical Therapy

The mainstay of therapy in acute mediastinitis secondary to cardiothoracic surgery includes clindamycin and ceftriaxone. The preferred regimen for preoperative prophylaxis against acute mediastinitis includes either a second generation cephalosporin or vancomycin.

Surgical Therapy

Aggressive surgical debridement is recommended among patients when combined with broad spectrum antibiotics that provide coverage against MRSA, beta-lactamase producing gram-negative organisms, and anaerobes.

Prevention

Effective measures for the primary prevention of mediastinitis include nasal decolonization, hand hygiene, and antibiotic prophylaxis. Effective measures for the secondary prevention of mediastinitis following sternotomy include reporting wound discharge to physician and aggressive treatment of hyperglycemia.

References

  1. 1.0 1.1 Koksal D, Bayiz H, Mutluay N, Koyuncu A, Demirag F, Dagli G; et al. (2013). "Fibrosing mediastinitis mimicking bronchogenic carcinoma". J Thorac Dis. 5 (1): E5–7. doi:10.3978/j.issn.2072-1439.2012.07.03. PMC 3548007. PMID 23372962.
  2. Abboud CS, Wey SB, Baltar VT (2004). "Risk factors for mediastinitis after cardiac surgery". Ann Thorac Surg. 77 (2): 676–83. doi:10.1016/S0003-4975(03)01523-6. PMID 14759458.
  3. 3.0 3.1 Mediastinitis: a potentially lethal infection. Thoracics (2012). http://thoracics.org/2012/03/03/mediastinitis-noncardiac-surgery/ Accessed on September 25, 2015.
  4. Lewandowski B, Pakla P, Wołek W, Jednakiewicz M, Nicpoń J (2014). "A fatal case of descending necrotizing mediastinitis as a complication of odontogenic infection. A case report". Kardiochir Torakochirurgia Pol. 11 (3): 324–8. doi:10.5114/kitp.2014.45685. PMC 4283893. PMID 26336443.
  5. 5.0 5.1 Acute Mediastinitis Following a Laparotomy for Small Bowel Obstruction. Journal of Current Surgery (2014) http://jcs.elmerpress.com/index.php/jcs/article/view/252 Accessed on September 28, 2015
  6. The Lancet. Google Books (2015). https://books.google.com/books?id=Zxw6AQAAMAAJ&pg=PA947&lpg=PA947&dq=the+lancet+mediastinitis+1896&source=bl&ots=izLFx5SXRB&sig=mXN15zc74xrPIn00rWnfoZ_NQ9Y&hl=en&sa=X&ved=0CB0Q6AEwAGoVChMIgPPf0aiByAIVAW0-Ch3LpgUe#v=onepage&q=lancet%20mediastinitis%201896&f=false Accessed on September 18, 2015
  7. Mediastinitis. Wikipedia (2015) https://en.wikipedia.org/wiki/Mediastinitis Accessed on September 21, 2015
  8. Histopathologic Overlap between Fibrosing Mediastinitis and IgG4-Related Disease. International Journal of Rheumatology (2012). http://www.hindawi.com/journals/ijr/2012/207056/ Accessed on September 25, 2015
  9. Konvalinka A, Erret L, Fong IW (2006). "Impact of treating Staphylococcus aureus nasal carreiers on wound infections in cardiac surgery". J Hosp Infect. 64 (2): 162–8. PMID 16930768.
  10. Kang DW, Canzian M, Beyruti R, Jatene FB (2006). "Sclerosing mediastinitis in the differential diagnosis of mediastinal tumors". J Bras Pneumol. 32 (1): 78–83. PMID 17273573.
  11. CDC/NHSN Surveillance Definitions for Specific Types of Infections. CDC (2015). http://www.cdc.gov/nhsn/PDFs/pscManual/17pscNosInfDef_current.pdf Accessed on September 21, 2015
  12. 12.0 12.1 Fibrosing mediastinitis. Radiopedia.org (2015) http://radiopaedia.org/articles/fibrosing-mediastinitis Accessed on October 2, 2015


Template:WikiDoc Sources